【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 11
2 Introduction 13
2.1 What Is This Report About? 13
3 Definitions of Markets/Categories Covered 14
3.1 In Vitro Diagnostics 14
3.1.1 Genetic Testing 14
3.1.2 Haematology 14
3.1.3 Immuno Chemistry 14
3.1.4 Infectious Immunology 14
3.1.5 Microbiology Culture 14
4 Company Snapshot 15
4.1 Key Information 15
4.2 Company Overview 15
4.3 Financial Performance 15
4.4 SWOT Snapshot 15
5 Business Description 16
5.1 Business Overview 16
5.2 Clinical Diagnostics 16
5.2.1 Overview 16
5.2.2 Financials 16
5.2.3 Capital Expenditure 16
5.2.4 Market View 16
5.3 Life Sciences 17
5.3.1 Overview 17
5.3.2 Financials 17
5.3.3 Capital Expenditure 17
5.3.4 Market View 17
5.4 Major Products and Services 17
5.4.1 Overview 17
6 History 18
7 Business Strategy 21
7.1 Mission Statement 21
8 SWOT Analysis 22
8.1 Overview 22
8.2 Bio-Rad Laboratories, Inc. Strengths 22
8.2.1 Diversified Segments Served 22
8.2.2 Global Presence 22
8.2.3 Product Development Efforts 23
8.3 Bio-Rad Laboratories, Inc. Weaknesses 23
8.3.1 Low Debt to Equity Ratio 23
8.3.2 Product Recalls 23
8.4 Bio-Rad Laboratories, Inc. Opportunities 23
8.4.1 Inorganic Growth Drivers 23
8.4.2 Rising Healthcare Expenditure in the US 24
8.4.3 Growth in Emerging Economies 24
8.4.4 Potential Life Sciences Market 24
8.5 Bio-Rad Laboratories, Inc. Threats 24
8.5.1 Intense Competition 24
8.5.2 Stringent Government Regulations 24
8.5.3 Changing Diagnostic Market Conditions 25
9 Competitors 26
10 Competitive Landscape 28
10.1 In Vitro Diagnostics (Genetic Testing), Global, Market Share (%), 2011 28
10.2 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Genetic Testing), by Region, Market Share (2011) 29
10.3 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Genetic Testing), by Country, Market Share (2011) 30
10.4 In Vitro Diagnostics (Haematology), Global, Market Share (%), 2011 32
10.5 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Haematology), by Region, Market Share (2011) 34
10.6 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Haematology), by Country, Market Share (2011) 35
10.7 In Vitro Diagnostics (Immuno Chemistry), Global, Market Share (%), 2011 37
10.8 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Immuno Chemistry), by Region, Market Share (2011) 39
10.9 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Immuno Chemistry), by Country, Market Share (2011) 40
10.10 In Vitro Diagnostics (Infectious Immunology), Global, Market Share (%), 2011 42
10.11 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Infectious Immunology), by Region, Market Share (2011) 44
10.12 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Infectious Immunology), by Country, Market Share (2011) 45
10.13 In Vitro Diagnostics (Microbiology Culture), Global, Market Share (%), 2011 47
10.14 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Microbiology Culture), by Region, Market Share (2011) 48
10.15 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Microbiology Culture), by Country, Market Share (2011) 49
11 Bio-Rad Laboratories, Inc. Medical Equipment Market Share Analysis 51
11.1 Bio-Rad Laboratories, Inc., In Vitro Diagnostics, Global, Category Revenue Share (2011) 51
11.2 Bio-Rad Laboratories, Inc., Asia-Pacific, Category Revenue Share (2011) 53
11.2.1 Bio-Rad Laboratories, Inc., Australia, Category Revenue Share (2011) 55
11.2.2 Bio-Rad Laboratories, Inc., China, Category Revenue Share (2011) 57
11.2.3 Bio-Rad Laboratories, Inc., India, Category Revenue Share (2011) 59
11.2.4 Bio-Rad Laboratories, Inc., Japan, Category Revenue Share (2011) 61
11.2.5 Bio-Rad Laboratories, Inc., Other Asia-Pacific, Category Revenue Share (2011) 63
11.3 Bio-Rad Laboratories, Inc., Europe, Category Revenue Share (2011) 65
11.3.1 Bio-Rad Laboratories, Inc., France, Category Revenue Share (2011) 67
11.3.2 Bio-Rad Laboratories, Inc., Germany, Category Revenue Share (2011) 69
11.3.3 Bio-Rad Laboratories, Inc., Italy, Category Revenue Share (2011) 71
11.3.4 Bio-Rad Laboratories, Inc., Spain, Category Revenue Share (2011) 73
11.3.5 Bio-Rad Laboratories, Inc., United Kingdom, Category Revenue Share (2011) 75
11.3.6 Bio-Rad Laboratories, Inc., Other Europe, Category Revenue Share (2011) 77
11.4 Bio-Rad Laboratories, Inc., Middle East and Africa, Category Revenue Share (2011) 79
11.5 Bio-Rad Laboratories, Inc., North America, Category Revenue Share (2011) 81
11.5.1 Bio-Rad Laboratories, Inc., Canada, Category Revenue Share (2011) 83
11.5.2 Bio-Rad Laboratories, Inc., United States, Category Revenue Share (2011) 85
11.6 Bio-Rad Laboratories, Inc., South and Central America, Category Revenue Share (2011) 87
11.6.1 Bio-Rad Laboratories, Inc., Brazil, Category Revenue Share (2011) 89
11.6.2 Bio-Rad Laboratories, Inc., Other South and Central America, Category Revenue Share (2011) 91
12 Share Holding Structure 93
13 Key Employees 94
14 Key Employee Biographies 95
15 Company Statement 96
16 Locations And Subsidiaries 97
16.1 Head Office 97
16.2 Other Locations & Subsidiaries 97
17 Financial Deals Landscape 100
17.1 Bio-Rad Laboratories, Inc., Deals Volume Summary, 2007 to YTD 2013 100
18 Bio-Rad Laboratories, Inc. Detailed Deal Summary 102
18.1 Asset Purchase 102
18.1.1 Bio-Rad Labs Acquires Cell Sorting System From Propel Labs 102
18.2 Partnerships 103
18.2.1 Chembio Diagnostics Enters Into A Licensing Agreement With Bio-Rad Labs 103
18.2.2 Innogenetics Signs Licensing Agreement With Bio-Rad Labs 104
18.2.3 Bio-Rad Labs Enters Into An Agreement With Axis-Shield 105
18.2.4 Bio-Rad Labs Enters Into Co-Marketing Agreement With Lamprogen For Fluorescent Particles 106
18.2.5 Bio-Rad Labs Enters Into Distribution Agreement With Myriad RBM For Multiplex Biomarker Kits 107
18.2.6 Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 108
18.2.7 Bio-Rad Expands Co-Marketing Agreement With Siemens Medical 109
18.2.8 Axis-Shield Signs Option Agreement With Bio-Rad Labs 110
18.2.9 Ariana Pharma Enters Into Collaboration With Bio-Rad Labs, Inserm And Beaujon Hospital 111
18.2.10 Chembio Signs DPP Development Agreement With Bio-Rad Labs 112
18.2.11 Sysmex America Enters Into Co-Marketing Agreement With Bio-Rad Labs 113
18.2.12 Bio-Rad Extends Agreement With Beckman Coulter 114
18.2.13 Bio-Rad Labs Signs Co-Marketing Agreement With Siemens Medical 115
18.2.14 Bio-Rad Labs Completes Public Offering Of Senior Notes Due 2020 For $425 Million 116
18.2.15 Bio-Rad Labs Completes Private Placement Of 8% Senior Subordinated Notes For $300 Million 117
18.3 Acquisition 118
18.3.1 Bio-Rad Labs Completes Acquisition Of AbD Serotec From MorphoSys For $70 Million 118
18.3.2 Bio-Rad Labs Acquires QuantaLife For $162 Million 120
18.3.3 Bio-Rad Labs Acquires Remaining Stake In DiaMed Thailand For $0.2 Million 121
18.3.4 Bio-Rad Labs Acquires Additional 39% Stake In DiaMed Spain For $3.4 Million 122
18.3.5 Bio-Rad Labs Acquires Diamed-France 123
18.3.6 Bio-Rad Labs Acquires Additional Stake In Diamed 124
18.3.7 Bio-Rad Labs Completes Acquisition Of Medical Diagnostics Segment From Biotest 125
18.3.8 Bio-Rad Labs Acquires Diamed 127
18.3.9 Bio-Rad Labs Acquires DiaMed Fennica And DiaMed (GB) 128
19 Recent Developments 129
19.1 Strategy And Business Planning 129
19.1.1 Aug 29, 2012: Bio-Rad Opens Digital Biology Center To Develop Products For R&D Markets Based On Its Droplet Digital Technology 129
19.2 Financial Announcements 129
19.2.1 Nov 06, 2012: Bio-Rad Reports Revenue Of $498.7m In Q3 2012 129
19.2.2 Aug 07, 2012: Bio-Rad Reports Revenue Of $510.4m In Q2 2012 130
19.2.3 May 02, 2012: Bio-Rad Reports Revenue Of $486.3m In Q1 2012 131
19.2.4 Feb 23, 2012: Bio-Rad Reports Revenue Of $2.1 Billion In 2011 131
19.2.5 Nov 01, 2011: Bio-Rad Reports Revenues Of $516.5m In Q3 2011 132
19.2.6 Aug 02, 2011: Bio-Rad Reports Revenue Of $521.7m In Q2 2011 133
19.2.7 May 03, 2011: Bio-Rad Reports Net Sales Of $485.1m In Q1 2011 134
19.2.8 Feb 24, 2011: Bio-Rad Reports Net Sales Of $1.9 Billion In 2010 134
19.2.9 Nov 02, 2010: Bio-Rad Reports Net Income Of $44.76 Million For Q3 2010 135
19.2.10 Aug 03, 2010: Bio-Rad Reports Net Income Of $37.95 Million In Q2 2010 136
19.2.11 May 04, 2010: Bio-Rad Reports Net Income Of $34.86 Million In Q1 2010 137
19.2.12 Feb 24, 2010: Bio-Rad Reports Net Income Of $144.6 Million In 2009 138
19.2.13 Nov 03, 2009: Bio-Rad Reports Net Income Of $38.5 Million In Q3 2009 139
19.2.14 Aug 04, 2009: Bio-Rad Reports Net Income Of $37.9 Million In Q2 2009 140
19.2.15 May 05, 2009: Bio-Rad Posts Net Income Of $30.3 Million In Q1 2009 141
19.2.16 Feb 26, 2009: Bio-Rad Posts Net Income Of $89.5 Million For 2008 141
19.2.17 Nov 06, 2008: Bio-Rad Reports 3Q 2008 Results 143
19.2.18 Aug 05, 2008: Bio-Rad Reports 2Q 2008 Results 144
19.2.19 May 06, 2008: Bio-Rad Reports Q1 2008 Results 145
19.2.20 Apr 11, 2008: Bio-Rad To Declare Q1 2008 Results 146
19.2.21 Feb 28, 2008: Bio-Rad Reports Q4 2007 Results 146
19.2.22 Nov 06, 2007: Bio-Rad Reports Q3 2007 Results 148
19.2.23 Oct 11, 2007: Bio-Rad To Announce Q3 2007 Results 149
19.2.24 Aug 07, 2007: Bio-Rad Reports Q2 2007 Results 149
19.2.25 May 03, 2007: Bio-Rad Reports Q1 2007 Results 150
19.2.26 Feb 22, 2007: Bio-Rad Reports Q4 2006 Results 151
19.3 Corporate Communications 152
19.3.1 Nov 01, 2011: Bio-Rad Appoints Deborah J Neff To Board 152
19.3.2 Mar 25, 2010: Bio-Rad Appoints Ted W. Love To Board 152
19.3.3 Oct 07, 2008: Bio-Rad Intent To List On The NYSE 153
19.3.4 Mar 05, 2007: Bio-Rad Announces AMEX Listing Compliance 153
19.3.5 Feb 20, 2007: Bio-Rad Appoints New Board Member 153
19.4 Legal and Regulatory 154
19.4.1 Apr 30, 2012: Vermillion Resolves Non-Contingent Claims With Bio-Rad 154
19.4.2 Aug 13, 2011: GE Healthcare And Bio-Rad Reach Settlement In Label-Free Detection Lawsuit 154
19.5 Product News 155
19.5.1 Jul 25, 2011: Bio-Rad Receives FDA Premarket Application Approval For GS HIV Combo Ag/Ab EIA 155
19.5.2 May 17, 2011: Bio-Rad Launches Antiphospholipid Syndrome IgG, IgM, And IgA Kits For BioPlex 2200 System 155
19.5.3 Apr 20, 2011: Researchers Use Bio-Rad’s ProteoMiner Technology To Profile Relative Protein Abundance And Identify Post-Translationally Modified Proteins In Human Saliva 156
19.5.4 Oct 13, 2010: Bio-Rad And Axis-Shield Announce FDA Clearance And US Launch Of Anti-CCP Test For Rheumatoid Arthritis For Bio-Rad’s BioPlex 2200 System 157
19.5.5 Jul 26, 2010: Bio-Rad Submits Premarket Approval Application To FDA For GS HIV Combo Ag/Ab EIA 157
19.5.6 Jun 30, 2010: Bio-Rad Introduces IH 1000 Blood Screening System 157
19.5.7 May 24, 2010: Bio-Rad Launches BioPlex 2200 MMRV IgG kit 158
19.5.8 Jan 05, 2010: Axis-Shield And Bio-Rad Introduces BioPlex 2200 Anti-CCP Test For Early Detection Of Rheumatoid Arthritis 158
19.5.9 Jun 01, 2009: Bio-Rad Laboratories Announces FDA Approval For ToRC IgG And HSV-1 & HSV-2 IgG Kits 158
19.5.10 Feb 11, 2008: Bio-Rad Launches Vasculitis Kit For Use On The Bioplex 2200 System 159
19.5.11 Nov 13, 2007: Bio-Rad Launches The In2it A1C Analyzer For Point-Of-Care Diabetes Testing 159
19.5.12 Nov 05, 2007: Bio-Rad Introduces Chromogenic Medium In The US For Rapid Screening Of MRSA 159
19.6 Product Approvals 160
19.6.1 Jul 25, 2011: Bio-Rad Receives FDA Premarket Application Approval For GS HIV Combo Ag/Ab EIA 160
19.6.2 Jun 01, 2009: Bio-Rad Laboratories Announces FDA Approval For ToRC IgG And HSV-1 & HSV-2 IgG Kits 160
19.7 Clinical Trials 161
19.7.1 Apr 20, 2011: Researchers Use Bio-Rad’s ProteoMiner Technology To Profile Relative Protein Abundance And Identify Post-Translationally Modified Proteins In Human Saliva 161
19.8 Other Significant Developments 162
19.8.1 Dec 19, 2012: Hospitals, Healthcare Providers To Benefit From New Multi-Source Premier Agreements For Blood Bank Analyzers, Reagents, Consumables And Service 162
20 Appendix 163
20.1 Research Methodology 164
20.2 Secondary Research 164
20.3 Primary Research 164
20.4 Models 165
20.5 Forecasts 165
20.6 Expert Panels 165
20.7 GlobalData Consulting 165
20.8 Currency Conversion 166
20.9 Contact Us 167
20.10 Disclaimer 167
【レポート販売概要】
■ タイトル：Bio-Rad Laboratories, Inc.：市場シェア分析■ 英文：Bio-Rad Laboratories, Inc. Market Share Analysis
■ 発行日：2013年2月28日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160480
■ 調査対象地域：グローバル
- 食肉の世界市場2019-2023About this market Growing prominence of private label brands to drive market growth. Private label products are manufactured and sold by retailers. Major retailers across the globe are introducing their own brands of meat products to capitalize on the growing demand for meat products among consumers. Private label processed meat products are becoming popular among consumers as they are affordable …
- Allengers Medical Systems Ltd.：市場シェア分析Allengers Medical Systems Ltd. Market Share Analysis Summary GlobalData’s new report, “Allengers Medical Systems Ltd. Market Share Analysis” provides in-depth information on Allengers Medical Systems Ltd.’s market position in the different medical equipment markets it operates in. The report provides Allengers Medical Systems Ltd. market share information in four key market categories – Lithotript …
- 小売における人工知能（AI）の世界市場2019-2023Global Artificial Intelligence (AI) Market: About this market Artificial Intelligence (Al) solutions are a convergence of hardware, software, and services to perform computing-based reasoning and understanding to emulate the human brain. Technavio’s artificial intelligence (AI) in retail sector market analysis considers sales from sales and marketing, in-store, planning, procurement and production …
- デンドリマーの世界市場2010-2025Dendrimers are widely investigated and utilized in biomedical applications, as they have multiple surface functional groups that can be used to target or label the dendrimer for imaging and drug delivery applications. They have found application in transdermal drug delivery systems and show potential in gene delivery and for enhancing the oral bioavailability of problematic drugs. Their are a numb …
- 小売向けRFIDの世界市場：RFIDタグ、RFIDリーダライタ、RFIDミドルウェアAbout RFID The radio-frequency identification (RFID) systems comprise tags, middleware, and interrogators, and are used by retail businesses to streamline their supply chain to help them achieve higher ROI by providing transparency and real-time data of inventory levels across supply chains. RFID systems for retail application reduce the delivery cycle time of goods and number of defects. With the …
- 世界のスマートグリッド政策動向2015Smart Grid Policy Handbook 2015 Summary “Smart Grid Policy Handbook 2015” is the latest policy report from GlobalData. It provides in-depth analysis of smart grid technology policies across major countries in the world: the US, Canada, Mexico, Brazil, the EU, Germany, the UK, France, Spain, Saudi Arabia, South Africa, India, China, Japan, South Korea, Singapore and Australia. Major topics include …
- パブリッククラウド/プライベートクラウド・ストレージのグローバル市場(2014-2019)The cloud storage market is segmented on the basis of a numerous solutions, components and their types, type of deployment, organization size, verticals and geographic regions. The total market size is estimated by adding up the individual market sizes of all the solutions such as primary storage solutions, backup storage solutions, cloud storage gateway solutions and data movement and access solu …
- スマートウォッチの世界市場2016-2020In terms of unit shipments, Technavios market research analyst predicts the global smartwatch market to grow at an impressive CAGR of approximately 12% by 2020. The widespread availability of smartwatches with advanced functionalities and features is expected to augment the interest of technology and fitness enthusiasts during the forecast period. The high compatibility of smartwatches with other …
- 前臨床イメージング（イン・ビボ）の世界市場：光学イメージング、PET、SPECT、CT、MRI、超音波、光音響イメージング、磁気粒子画像法、光学イメージング試薬、コントラスト剤、PETトレーサー、SPECTプローブThe global preclinical imaging market is expected to reach a value of USD 910.4 Million by 2021; growing at a CAGR of 6.2% during 2016-2021. A number of factors such as technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches …
- 非スコッチウイスキーのグローバル市場動向と予測（～2018）Non-Scotch whiskies in aggregate represent an enormous and growing category, with Irish whiskey in particular showing real momentum. This new joint IWSR/just-drinks report provides the latest insight into one of the most dynamic of categories. Yet despite the positive outlook for the whisk(e)y industry, there are challenges and potential challenges ahead. The report looks at the most importan …
- 世界の高性能計算（ハイ・パフォーマンス・コンピューティング）市場動向（2014～2018）TechNavio's analysts forecast the Global High Performance Computing (HPC) market to grow at a CAGR of 8.78 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing demand to maintain the data explosion. The Global HPC market has also been witnessing the growing demand for HPCaaS. However, the high implementation cost of compute resources could …
- 世界のMEMSジャイロスコープ市場動向（2012-2016）TechNavio’s analysts forecast the Global MEMS Gyroscope market to grow at a CAGR of 9.2 percent over the period 2012-2016. One of the key factors contributing to this market growth is the high demand for MEMS Gyroscopes in smartphones. The Global MEMS Gyroscope market has also been witnessing increasing usage in digital cameras. However, the high competition among vendors could pose a challenge to …
- 産業用伝送器（発信器）の世界市場：フロー伝送器、レベル伝送器、圧力伝送器、温度伝送器About Industrial Transmitters Industrial transmitters are widely used in all industrial applications for measuring, monitoring, testing, and automation. The value chain extends from the detection of process parameters in process industries to the analysis of specifications and characteristics of the final product. IoT has introduced new growth opportunities in the global industrial transmitters ma …
- オピオイド誘発性腸機能障害：グローバル臨床試験レビュー（2014年上半期）Opioid Induced Bowel Dysfunction Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Opioid Induced Bowel Dysfunction Global Clinical Trials Review, H1, 2014" provides data on the Opioid Induced Bowel Dysfunction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Opioid Induced Bowel Dysfunction. It inclu …
- ガムの世界市場：チューインガム、風船ガムAbout Gum Gum is generally consumed as a mouth freshening item and is available in varied sizes such as strips and pellets and flavors to attract children, teenagers and adults. The market is divided into two major categories based on type: chewing gum and bubble gum. Gum is made available to consumers through various distribution formats such as hypermarkets and supermarkets, independent retailer …
